SCHEMBL3453084

SCHEMBL3453084

Cc1ccc(-c2csc(N(CCC(=O)OC(C)(C)C)Cc3cccs3)n2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
KDM4E B2RXH2 4/20 0.47
HPGD P15428 1/20 0.47
GSTO1 P78417 1/20 0.46
KMT2A Q03164 5/20 0.43
MEN1 O00255 4/20 0.43
HTT P42858 1/20 0.43
RAD52 P43351 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
TRPM8 Q7Z2W7 2/20 0.41
POLB P06746 2/20 0.41
GRM1 Q13255 1/20 0.41
NPC1 O15118 5/20 0.40
RAB9A P51151 4/20 0.40
MAPT P10636 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
LMNA P02545 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
USP2 O75604 1/20 0.39
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13109421 0.86 ALDH1A1 (0.52) ALDH1A1KDM4EHPGDKMT2AMEN1
Hydrochloric Acid SCHEMBL3452662 0.85 ALDH1A1 (0.51) ALDH1A1KDM4EHPGDKMT2AMEN1
SCHEMBL3452015 0.81 GSTO1 (0.48) ALDH1A1KDM4EHPGDGSTO1KMT2A
SCHEMBL13109456 0.80 GCGR (0.54) ALDH1A1KDM4EHPGDGSTO1KMT2A
Hydrochloric Acid SCHEMBL3451988 0.80 GCGR (0.54) ALDH1A1KDM4EHPGDGSTO1KMT2A
SCHEMBL3452661 0.79 TSHR (0.52) ALDH1A1KDM4EHPGDGSTO1KMT2A
SCHEMBL13109445 0.78 RAB9A (0.55) ALDH1A1KDM4EKMT2AMEN1NPSR1
SCHEMBL13109455 0.78 GCGR (0.52) ALDH1A1GSTO1POLBSMN1; SMN2LMNA
Hydrochloric Acid SCHEMBL3453148 0.78 RAB9A (0.54) ALDH1A1KDM4EKMT2AMEN1NPSR1
Hydrochloric Acid SCHEMBL3453577 0.77 GCGR (0.51) ALDH1A1GSTO1POLBSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7820704-B2 Substituted heteroaryl derivatives, compositions, and methods of use TRANSTECH PHARMA, INC. (US) 2010-10-26 US disclosed
EP-1753735-A1 SUBSTITUTED THIAZOLE AND PYRIMIDINE DERIVATIVES AS MELANOCORTIN RECEPTOR MODULATORS Transtech Pharma, Inc. (US) 2007-02-21 EP disclosed
US-20050261294-A1 Substituted heteroaryl derivatives, compositions, and methods of use VTVX HOLDINGS I LLC 2005-11-24 US disclosed
WO-2005103022-A1 SUBSTITUTED THIAZOLE AND PYRIMIDINE DERIVATIVES AS MELANOCORTIN RECEPTOR MODULATORS TRANSTECH PHARMA, INC. (US) 2005-11-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261294-A1 Substituted heteroaryl derivatives, compositions, and methods of use MC5R, MC3R, MC4R ALDH1A1 1513/4885KDM4E 2378/4885HPGD 1777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.